- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 3.1 Amended and Restated Certificate of Incorporation of the Registrant, As Amended
- 3.2 Amended and Restated Bylaws of the Registrant, As Amended
- 4.3 Warrant to Purchase Stock Agreement, Dated July 17, 2007
- 4.4 Amendment No. 1 to Warrant to Purchase Stock Agreement, Dated February 19, 2009
- 4.5 Warrant to Purchase Stock Agreement, Dated August 19, 2008
- 4.6 Amendment No. 1 to Warrant to Purchase Stock Agreement, Dated February 19, 2009
- 4.7 Warrant to Purchase Stock Agreement, Dated October 10, 2008
- 4.8 Amendment No. 1 to Warrant to Purchase Stock Agreement, Dated February 19, 2009
- 4.9 Warrant to Purchase Stock Agreement, Dated October 10, 2008
- 4.10 Amendment No. 1 to Warrant to Purchase Stock Agreement, Dated February 19, 2009
- 4.11 Warrant to Purchase Stock Agreement, Dated October 10, 2008
- 4.12 Amendment No. 1 to Warrant to Purchase Stock Agreement, Dated February 19, 2009
- 4.13 Warrant to Purchase Stock Agreement, Dated October 10, 2008
- 4.14 Amendment No. 1 to Warrant to Purchase Stock Agreement, Dated February 19, 2009
- 4.15 Warrant to Purchase Stock Agreement, Dated October 10, 2008
- 4.16 Amendment No. 1 to Warrant to Purchase Stock Agreement, Dated February 19, 2009
- 4.17 Warrant to Purchase Stock Agreement, Dated October 10, 2008
- 4.18 Amendment No. 1 to Warrant to Purchase Stock Agreement, Dated February 19, 2009
- 10.9 Lease, Dated February 8, 2008
- 10.10 Loan and Security Agreement, Dated July 17, 2007
- 10.11 First Amendment to Loan and Security Agreement, Dated January 21, 2009
- 10.12 Second Amendment to Loan and Security Agreement, Dated March 23, 2009
- 10.13 Note and Warrant Purchase Agreement, Dated September 24, 2008
- 10.14 Amendment to Note and Warrant Purchase Agreement, Dated October 10, 2008
- 10.34 Arca Biopharma, Inc. 2004 Equity Incentive Plan
- 10.35 Arca Biopharma, Inc. 2004 Equity Incentive Plan
- 10.36 Arca Biopharma, Inc. 2004 Equity Incentive Plan
- 10.37 Arca Biopharma, Inc. 2004 Equity Incentive Plan
- 10.38 Arca Biopharma, Inc. 2004 Equity Incentive Plan
- 10.43 Amended and Restated Employment and Retention Agreement, Dated June 4, 2008
- 10.44 Amended and Restated Employment and Retention Agreement, Dated July 7, 2008
- 10.45 Amended and Restated Employment Agreement, Dated June 12, 2008
- 10.46 Assignment and Assumption Agreement, Dated January 26, 2009
- 10.47 Assignment and Assumption Agreement, Dated January 26, 2009
- 10.48 Assignment and Assumption Agreement, Dated January 26, 2009
- 10.50 Employment Agreement, Dated February 24, 2009
- 10.51 Employment Agreement, Dated February 23, 2009
- 10.52 Indemnity Agreement
- 21.1 Subsidiaries of Arca Biopharma, Inc. As of March 24, 2009
- 23.1 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification of Chief Executive Officer and Chief Financial Officer
Exhibit 10.46
ASSIGNMENT AND ASSUMPTION AGREEMENT
THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (the “Agreement”) is entered into as of January 26, 2009 (the “Effective Date”), by and between ARCA biopharma, Inc., a Delaware corporation, formerly known as Nuvelo, Inc. (“Assignee”), and ARCA biopharma Colorado, Inc., a Delaware corporation, formerly know as ARCA biopharma, Inc. (“Assignor”). Assignor and Assignee are each individually referred to herein as a “Party,” and collectively referred to as the “Parties.”
RECITALS
WHEREAS, Assignor desires to assign to Assignee, and Assignee desires to assume, all Assignor’s rights and obligations under that certain Amended and Restated Employment and Retention Agreement (the “Employment Agreement”) dated as of June 4, 2008, by and between Assignor and Dr. Michael R. Bristow.
NOW THEREFORE, for good and valuable consideration, the sufficiency of which is hereby acknowledged, the Parties agree as follows:
1.Assignment and Assumption.
1.1 Assignor hereby assigns, transfers and sets over to Assignee, and Assignee hereby assumes, all Assignor’s right, title, interest, powers, privileges, remedies, duties, liabilities and obligations under the Employment Agreement. As of the Effective Date, Assignee shall become entitled to all such right, title, interest, powers, privileges and remedies of Assignor and subject to all such duties, liabilities and obligations of Assignor, in each case as if Assignee were the original party to the Employment Agreement.
1.2 As of the Effective Date, the term “Company,” as used in the Employment Agreement, shall refer to Assignee, and Assignee will be bound by and perform Assignor’s obligations under the Employment Agreement.
2.Miscellaneous.
2.1 This Agreement shall be governed by and construed and interpreted in accordance with the substantive laws of the State of Colorado, without regard to conflicts of law provisions.
2.2. This Agreement constitutes the entire agreement among the Parties with respect to the subject matter hereof. This Agreement shall not be altered, amended, modified or otherwise changed by any oral communications of any kind or character, or by any written communication, unless signed by a duly authorized representative of each of the Parties.
[Signature Page Follows]
IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the date first written above.
ARCA BIOPHARMA, INC. | ||
By: | /s/ Christopher D. Ozeroff | |
Name: | Christopher D. Ozeroff | |
Title: | Executive Vice President of Business Development and General Counsel | |
ARCA BIOPHARMA COLORADO, INC. | ||
By: | /s/ Christopher D. Ozeroff | |
Name: | Christopher D. Ozeroff | |
Title: | Executive Vice President of Business Development and General Counsel |
ACKNOWLEDGED AND AGREED:
/s/ Dr. Michael R. Bristow |
Dr. Michael R. Bristow |